Lungenzentrum Maingau
- Address
- lock Available on a paid plan
Lungenzentrum Maingau - Pulmonary Research Center
Lungenzentrum Maingau is a specialized pulmonary research center dedicated to advancing the understanding and treatment of complex respiratory conditions. The center focuses on innovative therapeutic approaches for challenging chronic airway disorders that significantly impact patients' quality of life.
- Refractory and unexplained chronic cough syndromes
- Novel pharmacological interventions for persistent respiratory symptoms
- Advanced cough frequency monitoring and assessment technologies
The center's research portfolio emphasizes participation in Phase 3 clinical trials evaluating targeted therapies for refractory chronic cough, a debilitating condition that remains unresponsive to conventional treatments. Through rigorous clinical investigation, Lungenzentrum Maingau contributes to the development of next-generation cough suppression therapies and comprehensive safety assessments, helping to establish new treatment paradigms for patients suffering from chronic cough conditions that have previously lacked effective management options.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Lungenzentrum Maingau
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Randomized Double-Blind Study of Camlipixant (BLU-5937) Versus Placebo in Adults with Refractory or Unexplained Chronic Cough | Bellus Health Inc. | Phase III | Not Recruiting | Mar 2023 | Jul 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Camlipixant | 1 | Unknown | 2023-03-30 | 2023-03-30 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.